519 results on '"Hsiao, Liang‐Tsai"'
Search Results
2. Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases.
3. Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases.
4. Stem cell transplant for mantle cell lymphoma in Taiwan
5. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies
6. Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
7. Large B-cell lymphoma presenting primarily in bone marrow is frequently associated with haemophagocytic lymphohistiocytosis and has distinct cytogenetic features
8. Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area
9. Allogeneic hematopoietic stem cell transplantation for B‐cell lymphoma in Taiwan
10. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
11. Total knee replacement for patients with severe hemophilic arthropathy in Taiwan: A nationwide population-based retrospective study
12. Total knee replacement for patients with severe hemophilic arthropathy in Taiwan: A nationwide population-based retrospective study
13. Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients
14. Characterization of Androgen Receptor Complex Associated Protein (ARCAP) in hepatocellular carcinoma and liver
15. Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia
16. Clinical Implications and Outcomes of Bone Marrow Granulomas
17. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome
18. Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population
19. Acquired hemophilia A in a Taiwanese patient with bullous pemphigoid
20. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
21. Difference in thrombotic microangiopathy between concurrently and previously diagnosed systemic lupus erythematosus
22. Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantation
23. Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience
24. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma
25. No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation
26. Clinical-associated characteristics and microbiological features of bloodstream nontyphoidal salmonella infection in adult patients receiving allogeneic hematopoietic stem cell transplantation
27. Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
28. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients
29. Absolute lymphocyte count predicts response to rituximab-containing salvage treatment for relapsed/refractory B-cell non-Hodgkin's lymphoma with prior rituximab exposure
30. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher‐risk myelodysplastic syndromes
31. Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients.
32. Stem Cell Transplant for Mantle Cell Lymphoma in Taiwan
33. Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia
34. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.
35. Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
36. Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
37. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation
38. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation—association with chronic GVHD in late-onset adult patients
39. Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation
40. Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome
41. International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents
42. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma
43. Diffusion Capacity Predicts Long-term Survival After Allogeneic Bone Marrow Transplantation for Acute Lymphoblastic Leukemia
44. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin’s lymphoma: the single-institute experience in Taiwan
45. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma
46. Virus reactivation in high-risk non-Hodgkin’s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation
47. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation
48. Dramatic remission of anemia after thymectomy in a patient of idiopathic myelofibrosis with thymoma
49. Comparison of Myeloablative and Nonmyeloablative Hematopoietic Stem Cell Transplantation for Treatment of Chronic Myeloid Leukemia
50. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.